Synmosa Biopharma announces the record date for 2021 dividend through retained earning.
· Issued by Synmosa Biopharma Corp
Close
Today's Information
Provided by: SYNMOSA BIOPHARMA CORPORATION
SEQ_NO
2
Date of announcement
2022/06/22
Time of announcement
16:35:37
Subject
SYNMOSA announces the record date
for 2021 dividend through retained earning.
Date of events
2022/06/22
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or
shareholders' meeting, or of the decision by the company:2022/06/22
2.Type (ex-rights or ex-dividend) (please write "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-rights and dividend
3.Type and monetary amount of dividend distribution:
Cash dividends NT$150,162,802 ( NT$ 0.50702378 per share)
Stock dividends：NT$300,165,200 (NT$1.0135059 per share)
4.Ex-rights (Ex-dividend) date:2022/07/11
5.Last date before book closure:2022/07/12
6.Book closure starting date:2022/07/13
7.Book closure ending date:2022/07/17
8.Ex-rights (Ex-dividend) record date:2022/07/17
9.Deadline for applying the conversion of the debt voucher:NA
10.The closure period for the conversion of the debt voucher will
start from the date:NA
11.The closure period for the conversion of the debt voucher will
end on the date:NA
12.Payment date of cash dividend distribution:2022/08/15
13.Any other matters that need to be specified:
The proposal to issue new shares for capital increase from earnings
was Approved by the Financial Supervisory Commission on JUNE 17, 2022
